Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Free Access

Blood Gases and Retinopathy of Prematurity: The ELGAN Study

Hauspurg A.K.a · Allred E.N.b–d · Vanderveen D.K.e, f · Chen M.g · Bednarek F.J.h · Cole C.i · Ehrenkranz R.A.a, j · Leviton A.b, c · Dammann O.b, g, k

Author affiliations

aYale University School of Medicine, New Haven, Conn., bNeuroepidemiology Unit, Children’s Hospital Boston, cNeurology, Harvard Medical School, dBiostatistics, Harvard School of Public Health, eDepartment of Ophthalmology, Children’s Hospital Boston, fHarvard Medical School, and gDivision of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, Mass., hDivision of Neonatology, Department of Pediatrics, UMass Memorial, Worcester, Mass., iDivision of Neonatology, Department of Pediatrics, Boston Medical Center, Boston, Mass., jDepartment of Pediatrics, Yale University School of Medicine, New Haven, Conn., USA; kPerinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany

Corresponding Author

Prof. Olaf Dammann

Division of Newborn Medicine

Floating Hospital for Children at Tufts Medical Center

800 Washington St., Box 854, Boston, MA 02111 (USA)

Tel. +1 617 636 0240, Fax +1 617 636 3309, E-Mail odammann@tuftsmedicalcenter.org

Related Articles for ""

Neonatology 2011;99:104–111

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Objective: This study tested the hypothesis that preterm infants who had a blood gas derangement on at least 2 of the first 3 postnatal days are at increased risk for more severe retinopathy of prematurity (ROP). Method: 1,042 infants born before 28 weeks’ gestational age (GA) were included. An infant was considered to be exposed if his/her blood gas measure was in the highest or lowest quartile for GA on at least 2 of the first 3 postnatal days. Results: Multivariable models adjusting for confounders indicate that exposure to a PCO2 in the highest quartile predicts ROP (stage 3, 4 or 5: OR = 1.6, 95% CI = 1.1–2.3); zone 1: 2.0, 1.1–3.6; prethreshold/threshold: 1.9, 1.2–3.0; plus disease: 1.8, 1.1–2.9). Estimates are similar for a low pH for zone 1 (2.1, 1.2–3.8), prethreshold/threshold (1.8, 1.1–2.8), but did not quite achieve statistical significance for ROP stage 3, 4, or 5 (1.4, 0.9–2.0) and plus disease (1.5, 0.9–2.4). A PaO2 in the highest quartile for GA on at least 2 of the first 3 postnatal days was associated with a doubling of the risk of ROP in zone 1 (2.5, 1.4–4.4) and of prethreshold/threshold disease (2.1, 1.4–3.3), a 70% risk increase for plus disease (1.7, 1.04–2.8), while a 40% risk increase for ROP stage 3 or higher did not achieve statistical significance (1.4, 0.96–2.0). Conclusion: Infants exposed to high PCO2, low pH and high PaO2 appear to be at increased risk of more severe ROP.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 25, 2010
Accepted: March 24, 2010
Published online: July 30, 2010
Issue release date: February 2011

Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 4

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: http://www.karger.com/NEO

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.